Gilead Sciences Stock Z Score

GILD Stock  USD 73.25  0.24  0.33%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Gilead Sciences Piotroski F Score and Gilead Sciences Valuation analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
  
At present, Gilead Sciences' Capital Expenditures is projected to increase significantly based on the last few years of reporting. The current year's Long Term Debt To Capitalization is expected to grow to 0.53, whereas Additional Paid In Capital is forecasted to decline to about 730.9 M. At present, Gilead Sciences' Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 20.5 B, whereas Interest Expense is forecasted to decline to about 534.5 M.

Gilead Z Score Analysis

Gilead Sciences' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2021 2022 2023 2024 (projected)
Total Revenue27.3B27.3B27.1B28.5B
Interest Expense1.0B935M944M534.5M

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

Current Gilead Sciences Z Score

    
  3.48  
Most of Gilead Sciences' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gilead Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

Gilead Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Gilead Sciences is extremely important. It helps to project a fair market value of Gilead Stock properly, considering its historical fundamentals such as Z Score. Since Gilead Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Gilead Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Gilead Sciences' interrelated accounts and indicators.
0.90.950.70.93-0.05-0.12-0.270.990.610.620.730.470.560.530.910.240.87-0.77-0.510.820.690.96-0.250.690.210.730.24-0.58-0.48-0.26
0.90.90.640.87-0.1-0.2-0.530.880.530.420.650.360.470.320.760.270.82-0.64-0.440.750.670.89-0.370.460.340.610.29-0.55-0.48-0.48
0.950.90.540.950.03-0.18-0.360.90.590.520.740.410.460.370.790.410.86-0.65-0.40.720.630.88-0.30.640.180.630.22-0.62-0.39-0.36
0.70.640.540.48-0.27-0.01-0.240.750.190.620.210.350.540.410.64-0.180.74-0.81-0.670.890.740.70.180.580.060.690.3-0.54-0.6-0.28
0.930.870.950.48-0.03-0.27-0.280.90.760.440.770.540.40.470.860.340.74-0.61-0.220.70.480.9-0.490.560.370.520.32-0.46-0.23-0.21
-0.05-0.10.03-0.27-0.030.210.47-0.090.23-0.310.27-0.11-0.260.060.040.44-0.30.40.27-0.46-0.450.02-0.21-0.360.28-0.130.210.430.270.36
-0.12-0.2-0.18-0.01-0.270.210.08-0.09-0.05-0.03-0.12-0.080.02-0.05-0.04-0.17-0.070.0-0.02-0.090.0-0.110.34-0.02-0.22-0.12-0.10.03-0.050.02
-0.27-0.53-0.36-0.24-0.280.470.08-0.230.05-0.11-0.040.08-0.030.35-0.050.04-0.530.20.24-0.44-0.53-0.210.05-0.20.0-0.1-0.070.550.320.9
0.990.880.90.750.9-0.09-0.09-0.230.60.640.710.490.580.580.930.160.85-0.8-0.540.830.70.96-0.230.690.220.750.24-0.55-0.49-0.21
0.610.530.590.190.760.23-0.050.050.60.150.580.750.020.440.750.190.21-0.310.320.34-0.10.69-0.710.110.680.020.460.10.320.21
0.620.420.520.620.44-0.31-0.03-0.110.640.150.170.520.40.210.5-0.050.66-0.9-0.60.630.670.520.270.7-0.450.64-0.42-0.58-0.38-0.19
0.730.650.740.210.770.27-0.12-0.040.710.580.170.120.330.470.790.520.52-0.28-0.280.320.320.76-0.330.330.350.580.22-0.11-0.380.09
0.470.360.410.350.54-0.11-0.080.080.490.750.520.120.060.320.55-0.020.18-0.610.230.440.00.51-0.420.210.280.010.09-0.030.370.17
0.560.470.460.540.4-0.260.02-0.030.580.020.40.330.060.650.470.010.58-0.57-0.670.540.640.490.220.64-0.170.73-0.08-0.46-0.63-0.1
0.530.320.370.410.470.06-0.050.350.580.440.210.470.320.650.650.110.25-0.36-0.250.370.160.58-0.250.460.250.470.290.0-0.180.36
0.910.760.790.640.860.04-0.04-0.050.930.750.50.790.550.470.650.170.65-0.68-0.350.70.470.96-0.290.530.390.640.35-0.24-0.340.08
0.240.270.41-0.180.340.44-0.170.040.160.19-0.050.52-0.020.010.110.170.120.030.0-0.13-0.020.24-0.31-0.02-0.010.21-0.020.05-0.010.03
0.870.820.860.740.74-0.3-0.07-0.530.850.210.660.520.180.580.250.650.12-0.77-0.730.870.930.760.10.81-0.130.790.07-0.86-0.72-0.57
-0.77-0.64-0.65-0.81-0.610.40.00.2-0.8-0.31-0.9-0.28-0.61-0.57-0.36-0.680.03-0.770.6-0.84-0.76-0.72-0.13-0.70.19-0.70.150.60.470.23
-0.51-0.44-0.4-0.67-0.220.27-0.020.24-0.540.32-0.6-0.280.23-0.67-0.25-0.350.0-0.730.6-0.56-0.89-0.42-0.54-0.640.45-0.90.230.620.930.36
0.820.750.720.890.7-0.46-0.09-0.440.830.340.630.320.440.540.370.7-0.130.87-0.84-0.560.80.770.010.750.070.640.31-0.71-0.53-0.41
0.690.670.630.740.48-0.450.0-0.530.7-0.10.670.320.00.640.160.47-0.020.93-0.76-0.890.80.580.350.76-0.340.83-0.13-0.85-0.86-0.6
0.960.890.880.70.90.02-0.11-0.210.960.690.520.760.510.490.580.960.240.76-0.72-0.420.770.58-0.340.570.360.690.34-0.37-0.41-0.12
-0.25-0.37-0.30.18-0.49-0.210.340.05-0.23-0.710.27-0.33-0.420.22-0.25-0.29-0.310.1-0.13-0.540.010.35-0.340.23-0.740.3-0.47-0.22-0.5-0.04
0.690.460.640.580.56-0.36-0.02-0.20.690.110.70.330.210.640.460.53-0.020.81-0.7-0.640.750.760.570.23-0.380.71-0.08-0.76-0.55-0.26
0.210.340.180.060.370.28-0.220.00.220.68-0.450.350.28-0.170.250.39-0.01-0.130.190.450.07-0.340.36-0.74-0.38-0.250.780.380.310.18
0.730.610.630.690.52-0.13-0.12-0.10.750.020.640.580.010.730.470.640.210.79-0.7-0.90.640.830.690.30.71-0.25-0.11-0.53-0.84-0.14
0.240.290.220.30.320.21-0.1-0.070.240.46-0.420.220.09-0.080.290.35-0.020.070.150.230.31-0.130.34-0.47-0.080.78-0.110.090.10.02
-0.58-0.55-0.62-0.54-0.460.430.030.55-0.550.1-0.58-0.11-0.03-0.460.0-0.240.05-0.860.60.62-0.71-0.85-0.37-0.22-0.760.38-0.530.090.590.74
-0.48-0.48-0.39-0.6-0.230.27-0.050.32-0.490.32-0.38-0.380.37-0.63-0.18-0.34-0.01-0.720.470.93-0.53-0.86-0.41-0.5-0.550.31-0.840.10.590.38
-0.26-0.48-0.36-0.28-0.210.360.020.9-0.210.21-0.190.090.17-0.10.360.080.03-0.570.230.36-0.41-0.6-0.12-0.04-0.260.18-0.140.020.740.38
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

According to the company's disclosures, Gilead Sciences has a Z Score of 3.48. This is 48.44% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The z score for all United States stocks is 60.09% higher than that of the company.

Gilead Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gilead Sciences' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gilead Sciences could also be used in its relative valuation, which is a method of valuing Gilead Sciences by comparing valuation metrics of similar companies.
Gilead Sciences is currently under evaluation in z score category among related companies.

Gilead Sciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Gilead Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Gilead Sciences' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Gilead Sciences Institutional Holders

Institutional Holdings refers to the ownership stake in Gilead Sciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Gilead Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Gilead Sciences' value.
Shares
Norges Bank2023-12-31
16.1 M
Bank Of New York Mellon Corp2023-12-31
15.5 M
Northern Trust Corp2023-12-31
14 M
Legal & General Group Plc2023-12-31
12.5 M
Parnassus Investments, Llc2023-12-31
12 M
Amvescap Plc.2023-12-31
11.6 M
Nuveen Asset Management, Llc2023-12-31
11.5 M
Royal Bank Of Canada2023-12-31
10.6 M
Amundi2023-12-31
10.5 M
Blackrock Inc2023-12-31
122.8 M
Vanguard Group Inc2023-12-31
111.8 M

Gilead Fundamentals

About Gilead Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Gilead Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gilead Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gilead Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company was incorporated in 1987 and is headquartered in Foster City, California. Gilead Sciences operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 14400 people.

Gilead Sciences Investors Sentiment

The influence of Gilead Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Gilead. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Gilead Sciences' public news can be used to forecast risks associated with an investment in Gilead. The trend in average sentiment can be used to explain how an investor holding Gilead can time the market purely based on public headlines and social activities around Gilead Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Gilead Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Gilead Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Gilead Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Gilead Sciences.

Gilead Sciences Implied Volatility

    
  17.28  
Gilead Sciences' implied volatility exposes the market's sentiment of Gilead Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gilead Sciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gilead Sciences stock will not fluctuate a lot when Gilead Sciences' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gilead Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gilead Sciences' short interest history, or implied volatility extrapolated from Gilead Sciences options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Gilead Sciences Piotroski F Score and Gilead Sciences Valuation analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.